newsfilter
← Latest News
PR Newswire·

Novavax Announces Entering into a License Agreement with Pfizer

Novavax, Inc. (Nasdaq: NVAX) has entered into a license agreement with Pfizer for use of Novavax's Matrix-M® adjuvant. Under the terms of the...